To accelerate innovation, our Novo Nordisk Compound Sharing library offers novel peptide and protein analogues as well as antibodies for preclinical research. Through this open innovation initiative, we offer easy and free access to selected high-quality and well-characterised compounds to curious and passionate scientists from around the world.
Our Innovation Challenge aims at exploring, designing and co-developing solutions together with the wider innovation community. Through our series of challenges, we aim to explore, design and co-develop sustainable approaches to our business practices, which could bring life to the key innovations of tomorrow.
At work in our innovation lab
We have expertise across the pharmaceutical value, from the initial idea for a new treatment to making it accessible to people living with a serious chronic disease.
We rely on research technology platforms in our search for target molecules or pathways in the body that contributes to the development of a disease or its symptoms.
Recognising and understanding the ethical implications of our business is an ongoing process.